Home/Filings/4/0000950170-24-137416
4//SEC Filing

Glezer Eli N. 4

Accession 0000950170-24-137416

CIK 0001850906other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 5:32 PM ET

Size

7.0 KB

Accession

0000950170-24-137416

Insider Transaction Report

Form 4
Period: 2024-12-15
Glezer Eli N.
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-12-15+250155,083 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-12-152502,250 total
    Common Stock (250 underlying)
Footnotes (3)
  • [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The RSUs vest in 16 equal quarterly installments over four years measured from March 15, 2023.

Documents

1 file

Issuer

Singular Genomics Systems, Inc.

CIK 0001850906

Entity typeother

Related Parties

1
  • filerCIK 0001859694

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:32 PM ET
Size
7.0 KB